GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Thalys Medical Technology Group Corp (SHSE:603716) » Definitions » Shares Outstanding (EOP)

Thalys Medical Technology Group (SHSE:603716) Shares Outstanding (EOP) : 201 Mil (As of Sep. 2024)


View and export this data going back to 2016. Start your Free Trial

What is Thalys Medical Technology Group Shares Outstanding (EOP)?

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. Thalys Medical Technology Group's shares outstanding for the quarter that ended in Sep. 2024 was 201 Mil.

Thalys Medical Technology Group's quarterly shares outstanding increased from Jun. 2024 (201 Mil) to Sep. 2024 (201 Mil). It means Thalys Medical Technology Group issued new shares from Jun. 2024 to Sep. 2024 .

Thalys Medical Technology Group's annual shares outstanding declined from Dec. 2022 (204 Mil) to Dec. 2023 (202 Mil). It means Thalys Medical Technology Group bought back shares from Dec. 2022 to Dec. 2023 .


Thalys Medical Technology Group Shares Outstanding (EOP) Historical Data

The historical data trend for Thalys Medical Technology Group's Shares Outstanding (EOP) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Thalys Medical Technology Group Shares Outstanding (EOP) Chart

Thalys Medical Technology Group Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shares Outstanding (EOP)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 205.14 205.03 205.02 203.52 202.10

Thalys Medical Technology Group Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Shares Outstanding (EOP) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 202.10 202.10 201.32 201.32 201.34

Competitive Comparison of Thalys Medical Technology Group's Shares Outstanding (EOP)

For the Diagnostics & Research subindustry, Thalys Medical Technology Group's Shares Outstanding (EOP), along with its competitors' market caps and Shares Outstanding (EOP) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Thalys Medical Technology Group's Shares Outstanding (EOP) Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Thalys Medical Technology Group's Shares Outstanding (EOP) distribution charts can be found below:

* The bar in red indicates where Thalys Medical Technology Group's Shares Outstanding (EOP) falls into.


;
;

Thalys Medical Technology Group Shares Outstanding (EOP) Calculation

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. They have voting rights and represent ownership in the corporation by the person that holds the shares. They should be distinguished from treasury shares, which are shares held by the corporation itself, having no exercisable rights.

Shares outstanding can be calculated as either basic or fully diluted. The fully diluted shares outstanding count includes diluting securities, such as options, warrants or convertibles.

Please note: GuruFocus named Shares Outstanding (EOP) is the shares for that end of period. It is usually used to calculate balance sheet related items, such as Book Value per Share, etc. While Shares Outstanding (Diluted Average) and Shares Outstanding (Basic Average) are the weighted average shares over a period of time (a year, a quarter, or so). They are usually used to calculate income statement or cashflow statement related items, such as Earnings per Share (Diluted), etc.


Thalys Medical Technology Group  (SHSE:603716) Shares Outstanding (EOP) Explanation

A company may buy back shares or issue shares in any fiscal period. If a company buys back shares, we should observe that the total number of shares decline. If the company issues new shares, the number of shares outstanding increases.

Usually the presence of treasury shares and a history of buyback are good indicators that company has competitive advantage. But studies have shown that companies usually buy back at wrong time. Buying back shares below its intrinsic value increases value for remaining shareholders. Buying back overvalued shares destroys value for existing shareholders.


Be Aware

Warren Buffett looks for consistency and upward long term trend. Because of share repurchase it is possible for net earnings trend to differ from EPS trend. He preferred net income over EPS. The companies with durable competitive advantage companies report higher % net earnings to total revenues.

Important: If a company is showing net earnings history greater than 20% on total revenues, it is probably benefiting from a long term competitive advantage.

If net earnings is less than 10%, likely to be in a highly competitive business.


Thalys Medical Technology Group Shares Outstanding (EOP) Related Terms

Thank you for viewing the detailed overview of Thalys Medical Technology Group's Shares Outstanding (EOP) provided by GuruFocus.com. Please click on the following links to see related term pages.


Thalys Medical Technology Group Business Description

Traded in Other Exchanges
N/A
Address
1310 Jinshan Avenue, Dongxihu District, Hubei Province, Wuhan, CHN, 430040
Thalys Medical Technology Group Corp is engaged in intensive sales business, pure sales, and research and development, production and sales of independent in vitro diagnostic products.
Executives
Wang Jun Ming senior management
Wang Zheng senior management
Wang Wen Bin senior management
Liu Wen Hao Director
Huang Yong Xi senior management
Lei Xian Kun Director
Fan Li Director
Liu Yuan senior management
Wan Li Bo senior management
Wen Wei Director
Chou Jian senior management
Song Yu Director

Thalys Medical Technology Group Headlines

No Headlines